The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Rigel
Stock and Other Ownership Interests - Rigel
Safety and efficacy of olutasidenib treatment in elderly patients with relapsed/refractory mIDH1 acute myeloid leukemia.
 
Stéphane De Botton
Honoraria - Abbvie; Agios; Astellas Pharma; Bayer; Celgene; Daiichi Sankyo; Forma Therapeutics; Janssen; Seagen; Syros Pharmaceuticals
Consulting or Advisory Role - Abbvie; Agios; Astellas Pharma; Bayer; Celgene; Daiichi Sankyo; Janssen; Novartis; Pfizer; Pierre Fabre; SERVIER; Syros Pharmaceuticals
Speakers' Bureau - Celgene
Research Funding - Agios; Forma Therapeutics
 
Brian Andrew Jonas
Consulting or Advisory Role - Abbvie; BMS; Daiichi Sankyo; Genentech; Gilead Sciences; GlycoMimetics; Kura Oncology; Kymera; Rigel; Servier; Syndax
Research Funding - Abbvie (Inst); Amgen (Inst); Aptose Biosciences (Inst); AROG (Inst); Biomea Fusion (Inst); BMS (Inst); Celgene (Inst); FORMA Therapeutics (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); Glycomimetics (Inst); Hanmi (Inst); Immune-Onc Therapeutics (Inst); Jazz Pharmaceuticals (Inst); Kymera (Inst); Loxo (Inst); Pfizer (Inst); Pharmacyclics (Inst); Roche (Inst); Treadwell Therapeutics (Inst)
Travel, Accommodations, Expenses - Rigel
Other Relationship - Gilead Sciences; GlycoMimetics
 
P. Brent Ferrell
Research Funding - Novartis (Inst)
 
Mwe Mwe Chao
No Relationships to Disclose
 
Alice S. Mims
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Daiichi Sankyo; Foghorn Therapeutics; Jazz Pharmaceuticals; Rigel; Ryvu Therapeutics